Albert J Arias MD MS

Addiction, Psychopharmacology

Associate Professor of Psychiatry Associate Division Chair, Addiction Psychiatry Virginia Commonwealth University School of Medicine

Summary

Dr. Albert Arias is a psychiatrist based in Richmond, VA, specializing in addiction and psychopharmacology. He completed his residency in psychiatry at the University of Connecticut and holds an M.D. from Michigan State University College of Human Medicine, as well as an M.S. in Clinical and Translational Research. Dr. Arias is an Associate Professor at the Yale School of Medicine and has a specific focus on bipolar disorder, schizophrenia, psychotherapy, and addiction psychiatry. His research includes publications on alcohol use disorders and the effectiveness of treatments for depression, anxiety, and substance use. Dr. Arias has participated in various clinical trials aimed at treating alcohol dependence and has been recognized with numerous awards, including the Research Award from the American Academy of Addiction Psychiatry.

University of Connecticut (Health Center)M.S., Clinical and Translational Research, 2008 - 2010
University of ConnecticutResidency, Psychiatry, 2002 - 2006
Cincinnati General Hospital2001 - 2002
Michigan State University College of Human MedicineClass of 2001, M.D.
Michigan State UniversityB.S., Human Physiology with a Specialization in Health and Humanities , 1993 - 1997

Research Travel Award for Minorities American College of Neuropsychopharmacology, 2009
Junior Investigators American Psychiatric Association Research Colloquium, 2008
Research Award (for resident, fellow, and early-career level investigators) American Academy of Addiction Psychiatry, 2005
Finalist for the MSU Spartan Scholarship Competition 1993
National Merit Scholar 1993
Join now to see all

PubMed

Journal Articles

Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics.
Jones MZ, Alroy J, Rutledge JC, Taylor JW, Alvord EC, Jr., Toone J, Applegarth D, Hopwood JJ, Skutelsky E, Ianelli C, Thorley-Lawson D, Mitchell-Herpolsheimer C, Arias..., J Neuropathol Exp Neurol; 56(10):1158-67
Memantine for Alcohol Dependence: An Open-label Pilot Study.
Arias AJ, Feinn R, Covault J, Kranzler HR, Addictive Disorders & Their Treatment; 6(2):77-83
Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Cohen E, Feinn R, Arias A, Kranzler HR, Drug Alcohol Depend; 86(2-3):214-21
Eating Disorder Symptoms and Alcohol Use Among Adolescents in Substance Abuse Treatment.
Arias JE, Hawke JM, Arias AJ, Kaminer Y, Substance Abuse: Research and Treatment; 3:81
Join now to see all

Books/Book Chapters

Alcohol Research & Health.
Chapter: Treatment of co-occurring alcohol and other drug use disorders
Page 155 - 167Arias, A. J. and Kranzler, H. R
Clinical Manual of Adolescent Substance Abuse Treatment.
Chapter: Biomarker Testing for Substance Use in Adolescents
Arias JE, Arias AJ, Kaminer YAmerican Psychiatric Press Inc

Lectures

Human mucopolysaccharidosis IIID: Clinical, biochemical, morphological and immunohistochemical characteristics.
Annual Meeting of the American Association of Neuropathology
A Case of Somatization Disorder.
UCONN Department of Psychiatry Grand Rounds
Association of an Asn40Asp (A118G) Polymorphism in the Mu-opioid Receptor Gene with Substance Dependence: A Meta-analysis.
Annual Meeting of the American Academy of Addiction Psychiatry
Catatonia.
UCONN Department of Psychiatry Grand Rounds
Implementing Adherence-Enhancing Strategies in Clinical Practice: Negotiating Within the Therapeutic Alliance.
American Psychiatric Association Annual Meeting
Overview of Treatment Options for the Dually-Diagnosed Alcohol Dependent Patient.
UCHC Department of Psychiatry Grand Rounds
Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers.
The American Psychiatric Association Annual meeting
Managing Alcohol Dependence in Primary Care.
Grand Rounds, University of Connecticut School of Medicine, Internal Medicine Department
Placebo Controlled Trial of Zonisamide for Alcohol Dependence.
American College of Neuropsychopharmacology Annual Meeting
Join now to see all

Beyond Dry January: Addressing the Health Impacts of Alcohol ConsumptionFebruary 23rd, 2024

Psilocybin-Assisted Treatment of Cocaine Use DisorderVIRGINIA COMMONWEALTH UNIVERSITY2025–2027
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderVIRGINIA COMMONWEALTH UNIVERSITY2022–2025
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use DisordersVIRGINIA COMMONWEALTH UNIVERSITY2020–2025
Effectiveness of Zonisamide in Treating Alcohol Dependent VeteransCSR&D- Veterans Affairs Merit Award2014–Present
Zonisamide treatment of AUD: efficacy and mechanism of actionNIAAA2016–2021
Effectiveness of Zonisamide in Alcohol Dependent VeteransVeterans Affairs Clinical Sciences Research and Development2014–2019
Alcohol Dependence: Pharmacotherapy, Pharmacogenetics, And GeneticsNational Institute On Alcohol Abuse And Alcoholism2011–2012
Alcohol Dependence: Pharmacotherapy, Pharmacogenetics, And GeneticsNational Institute On Alcohol Abuse And Alcoholism2010
Clinical Trial: Zonisamide Versus PlaceboNational Center For Research Resources2008
Zonisamide Versus PlaceboNational Center For Research Resources2007